Skip to main content
. 2016 Oct 31;161(1):63–72. doi: 10.1007/s10549-016-4033-3

Table 1.

Baseline characteristics

PLD N = 105 Capecitabine N = 105
N (%) N (%)
Median age of patient, years (range) 62 (36–82) 63 (22–85)
ECOG performance status
 Missing 5 (4) 1 (1)
 0 51 (49) 53 (50)
 1 43 (41) 45 (43)
 2 6 (6) 5 (5)
 3 0 1 (1)
Prior anthracyclines
 Yes 39 (37) 38 (36)
 No 66 (63) 67 (64)
Menopausal status
 Premenopausal 5 (5) 5 (5)
 Postmenopausal 85 (83) 87 (85)
 Not known/examined 15 (14) 13 (12)